vs
GRID DYNAMICS HOLDINGS, INC.（GDYN）与Pacira BioSciences, Inc.（PCRX）财务数据对比。点击上方公司名可切换其他公司
Pacira BioSciences, Inc.的季度营收约是GRID DYNAMICS HOLDINGS, INC.的1.9倍（$196.9M vs $106.2M），GRID DYNAMICS HOLDINGS, INC.同比增速更快（5.9% vs 5.1%），Pacira BioSciences, Inc.自由现金流更多（$43.5M vs $6.1M），过去两年GRID DYNAMICS HOLDINGS, INC.的营收复合增速更高（15.3% vs 8.5%）
Escape Dynamics Inc.是一家总部位于科罗拉多州的科技企业，活跃于2010年至2015年，核心业务方向是研发可单级入轨、依靠电磁驱动的可重复使用航天飞机，并推动该项目实现商业化落地。
Pacira BioSciences是一家专科制药企业，专注于非阿片类疼痛管理药物的研发与商业化，核心产品线面向术后镇痛场景，服务以美国为主的医院、门诊手术中心等医疗服务机构，同时推进部分国际市场的拓展工作。
GDYN vs PCRX — 直观对比
营收规模更大
PCRX
是对方的1.9倍
$106.2M
营收增速更快
GDYN
高出0.7%
5.1%
自由现金流更多
PCRX
多$37.4M
$6.1M
两年增速更快
GDYN
近两年复合增速
8.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $106.2M | $196.9M |
| 净利润 | $306.0K | — |
| 毛利率 | 34.0% | 79.5% |
| 营业利润率 | 0.5% | 1.2% |
| 净利率 | 0.3% | — |
| 营收同比 | 5.9% | 5.1% |
| 净利润同比 | -93.2% | — |
| 每股收益（稀释后） | $0.01 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GDYNPCRX
| Q4 25 | $106.2M | $196.9M | ||
| Q3 25 | $104.2M | $179.5M | ||
| Q2 25 | $101.1M | $181.1M | ||
| Q1 25 | $100.4M | $168.9M | ||
| Q4 24 | $100.3M | $187.3M | ||
| Q3 24 | $87.4M | $168.6M | ||
| Q2 24 | $83.0M | $178.0M | ||
| Q1 24 | $79.8M | $167.1M |
净利润GDYNPCRX
| Q4 25 | $306.0K | — | ||
| Q3 25 | $1.2M | $5.4M | ||
| Q2 25 | $5.3M | $-4.8M | ||
| Q1 25 | $2.9M | $4.8M | ||
| Q4 24 | $4.5M | — | ||
| Q3 24 | $4.3M | $-143.5M | ||
| Q2 24 | $-817.0K | $18.9M | ||
| Q1 24 | $-3.9M | $9.0M |
毛利率GDYNPCRX
| Q4 25 | 34.0% | 79.5% | ||
| Q3 25 | 33.3% | 80.9% | ||
| Q2 25 | 34.1% | 77.4% | ||
| Q1 25 | 36.8% | 79.7% | ||
| Q4 24 | 36.9% | 78.7% | ||
| Q3 24 | 37.4% | 76.9% | ||
| Q2 24 | 35.6% | 75.1% | ||
| Q1 24 | 34.7% | 71.6% |
营业利润率GDYNPCRX
| Q4 25 | 0.5% | 1.2% | ||
| Q3 25 | -0.2% | 3.5% | ||
| Q2 25 | -0.1% | 4.7% | ||
| Q1 25 | -2.0% | 1.2% | ||
| Q4 24 | 1.3% | 13.2% | ||
| Q3 24 | 2.4% | -82.8% | ||
| Q2 24 | 0.0% | 15.9% | ||
| Q1 24 | -6.9% | 7.9% |
净利率GDYNPCRX
| Q4 25 | 0.3% | — | ||
| Q3 25 | 1.1% | 3.0% | ||
| Q2 25 | 5.2% | -2.7% | ||
| Q1 25 | 2.9% | 2.8% | ||
| Q4 24 | 4.5% | — | ||
| Q3 24 | 4.9% | -85.1% | ||
| Q2 24 | -1.0% | 10.6% | ||
| Q1 24 | -4.9% | 5.4% |
每股收益（稀释后）GDYNPCRX
| Q4 25 | $0.01 | $0.05 | ||
| Q3 25 | $0.01 | $0.12 | ||
| Q2 25 | $0.06 | $-0.11 | ||
| Q1 25 | $0.03 | $0.10 | ||
| Q4 24 | $0.06 | $0.38 | ||
| Q3 24 | $0.05 | $-3.11 | ||
| Q2 24 | $-0.01 | $0.39 | ||
| Q1 24 | $-0.05 | $0.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $342.1M | $238.4M |
| 总债务越低越好 | — | $372.2M |
| 股东权益账面价值 | $542.1M | $693.1M |
| 总资产 | $612.9M | $1.3B |
| 负债/权益比越低杠杆越低 | — | 0.54× |
8季度趋势，按日历期对齐
现金及短期投资GDYNPCRX
| Q4 25 | $342.1M | $238.4M | ||
| Q3 25 | $338.6M | $246.3M | ||
| Q2 25 | $336.8M | $445.9M | ||
| Q1 25 | $325.5M | $493.6M | ||
| Q4 24 | $334.7M | $484.6M | ||
| Q3 24 | $231.3M | $453.8M | ||
| Q2 24 | $256.0M | $404.2M | ||
| Q1 24 | $249.4M | $325.9M |
总债务GDYNPCRX
| Q4 25 | — | $372.2M | ||
| Q3 25 | — | $376.7M | ||
| Q2 25 | — | $580.5M | ||
| Q1 25 | — | $583.4M | ||
| Q4 24 | — | $585.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益GDYNPCRX
| Q4 25 | $542.1M | $693.1M | ||
| Q3 25 | $537.7M | $727.2M | ||
| Q2 25 | $532.2M | $757.8M | ||
| Q1 25 | $517.4M | $798.5M | ||
| Q4 24 | $517.8M | $778.3M | ||
| Q3 24 | $400.2M | $749.6M | ||
| Q2 24 | $388.4M | $879.3M | ||
| Q1 24 | $382.8M | $892.2M |
总资产GDYNPCRX
| Q4 25 | $612.9M | $1.3B | ||
| Q3 25 | $613.2M | $1.3B | ||
| Q2 25 | $608.9M | $1.5B | ||
| Q1 25 | $590.9M | $1.6B | ||
| Q4 24 | $592.2M | $1.6B | ||
| Q3 24 | $477.3M | $1.5B | ||
| Q2 24 | $443.6M | $1.6B | ||
| Q1 24 | $435.3M | $1.6B |
负债/权益比GDYNPCRX
| Q4 25 | — | 0.54× | ||
| Q3 25 | — | 0.52× | ||
| Q2 25 | — | 0.77× | ||
| Q1 25 | — | 0.73× | ||
| Q4 24 | — | 0.75× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.9M | $43.7M |
| 自由现金流经营现金流 - 资本支出 | $6.1M | $43.5M |
| 自由现金流率自由现金流/营收 | 5.7% | 22.1% |
| 资本支出强度资本支出/营收 | 3.6% | 0.1% |
| 现金转化率经营现金流/净利润 | 32.34× | — |
| 过去12个月自由现金流最近4个季度 | $25.3M | $136.7M |
8季度趋势，按日历期对齐
经营现金流GDYNPCRX
| Q4 25 | $9.9M | $43.7M | ||
| Q3 25 | $7.0M | $60.8M | ||
| Q2 25 | $14.4M | $12.0M | ||
| Q1 25 | $9.4M | $35.5M | ||
| Q4 24 | $7.1M | $33.1M | ||
| Q3 24 | $9.2M | $53.9M | ||
| Q2 24 | $10.7M | $53.2M | ||
| Q1 24 | $3.2M | $49.1M |
自由现金流GDYNPCRX
| Q4 25 | $6.1M | $43.5M | ||
| Q3 25 | $2.9M | $57.0M | ||
| Q2 25 | $10.2M | $9.3M | ||
| Q1 25 | $6.0M | $26.9M | ||
| Q4 24 | $4.4M | $31.0M | ||
| Q3 24 | $5.9M | $49.8M | ||
| Q2 24 | $8.0M | $51.6M | ||
| Q1 24 | $43.0K | $46.3M |
自由现金流率GDYNPCRX
| Q4 25 | 5.7% | 22.1% | ||
| Q3 25 | 2.8% | 31.7% | ||
| Q2 25 | 10.1% | 5.1% | ||
| Q1 25 | 6.0% | 15.9% | ||
| Q4 24 | 4.4% | 16.6% | ||
| Q3 24 | 6.8% | 29.6% | ||
| Q2 24 | 9.7% | 29.0% | ||
| Q1 24 | 0.1% | 27.7% |
资本支出强度GDYNPCRX
| Q4 25 | 3.6% | 0.1% | ||
| Q3 25 | 3.9% | 2.2% | ||
| Q2 25 | 4.1% | 1.5% | ||
| Q1 25 | 3.3% | 5.1% | ||
| Q4 24 | 2.6% | 1.1% | ||
| Q3 24 | 3.7% | 2.4% | ||
| Q2 24 | 3.2% | 0.9% | ||
| Q1 24 | 4.0% | 1.7% |
现金转化率GDYNPCRX
| Q4 25 | 32.34× | — | ||
| Q3 25 | 5.92× | 11.20× | ||
| Q2 25 | 2.73× | — | ||
| Q1 25 | 3.21× | 7.37× | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 2.15× | — | ||
| Q2 24 | — | 2.82× | ||
| Q1 24 | — | 5.47× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GDYN
| Other | $30.6M | 29% |
| Technology Media And Telecom | $30.1M | 28% |
| Financial Service | $24.3M | 23% |
| Manufactured Product Other | $10.8M | 10% |
| Related Party | $7.6M | 7% |
| Health Care | $2.8M | 3% |
PCRX
| EXPAREL | $155.8M | 79% |
| ZILRETTA | $33.0M | 17% |
| Iovera | $7.0M | 4% |
